| 查看: 2858 | 回复: 9 | ||
| 当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖 | ||
[求助]
谁帮忙查个盐酸美金刚的标准，谢谢了。
|
||
|
谁帮忙查个盐酸美金刚的标准，谢谢了。 一定要USP36的， |
回复此楼» 猜你喜欢
2026博士申请-药物化学方向（小分子化合物合成）
已经有4人回复
-
大肠杆菌临床分离菌株ETEC菌株求购
已经有5人回复
-
药理学论文润色/翻译怎么收费?
已经有253人回复
-
钯碳氢气还原脱cbz产物伯胺出现甲基化。
已经有2人回复
-
求助《化工原理》第四版 柴诚敬、贾绍义 课件
已经有1人回复
-
酯类化合物柱层析极性较大，使用醇类溶剂，怎么避免酯交换
已经有2人回复
-
求助骆广生微化工技术书籍
已经有1人回复
-
求助冯连芳、张才亮的《聚合过程强化技术》
已经有0人回复
-
2026考博
已经有0人回复
-
浙江中医药大学张勇民院士2026年博士研究生招生
已经有2人回复
-
硫醚氧化
已经有0人回复
» 本主题相关价值贴推荐，对您同样有帮助:
qiuqinglei5020 
金虫 (小有名气)
硫酸大师
- 应助: 2 (幼儿园)
- 金币: 131
- 散金: 27
- 红花: 6
- 帖子: 138
- 在线: 71.3小时
- 虫号: 1083266
- 注册: 2010-08-27
- 性别: GG
- 专业: 药物分析
4楼2013-10-20 12:24:43
e_liang369
金虫 (正式写手)
- 应助: 340 (大学生)
- 金币: 2491.9
- 红花: 12
- 帖子: 819
- 在线: 737.3小时
- 虫号: 2456033
- 注册: 2013-05-09
- 性别: GG
- 专业: 药物分析
2楼2013-10-18 12:28:32
3楼2013-10-19 20:33:53
06药学
木虫 (著名写手)
- DRDEPI: 1
- 应助: 24 (小学生)
- 金币: 6679.8
- 散金: 16
- 红花: 3
- 帖子: 1041
- 在线: 543.6小时
- 虫号: 525221
- 注册: 2008-03-14
- 性别: GG
- 专业: 药物分析
【答案】应助回帖
★ ★ ★ ★ ★ ★ ★ ★ ★ ★
感谢参与，应助指数 +1
hfsr(zhychen2008代发): 金币+10, 多谢回帖交流 2013-10-20 23:08:46
感谢参与，应助指数 +1
hfsr(zhychen2008代发): 金币+10, 多谢回帖交流 2013-10-20 23:08:46
|
Memantine Hydrochloride Tablets DEFINITION Memantine Hydrochloride Tablets contain an amount of memantine hydrochloride equivalent to NLT 90.0% and NMT 110.0% of the labeled amount of memantine hydrochloride (C12H21N ·HCl). IDENTIFICATION • A. Infrared Absorption 197K Analytical range: 4000 to 400 cm –1 Standard: 6.7 mg/mL of USP Memantine Hydrochloride RS in dichloromethane. Shake for 10 min, and pass through a suitable filter. Evaporate the solvent at room temperature. Collect the residue powder, and dry at 60 for 15 min. Prepare an approximate 1% (w/w) dispersion of the sample in potassium bromide. Sample: 6.7 mg/mL of Memantine Hydrochloride in dichloromethane from NLT 20 crushed Tablets. Shake for 10 min, and centrifuge for 10 min. Pass the supernatant through a suitable filter. Evaporate the solvent at room temperature. Collect the residue powder, and dry at 60 for 15 min. Prepare an approximate 1% (w/w) dispersion of the sample in potassium bromide. Acceptance criteria: Fingerprint region of the Standard and Sample spectrum exhibit maxima at the same wave numbers. • B. The retention time of the memantine peak in the Sample solution corresponds to that of the memantine peak in the Standard solution, as obtained in the Assay. ASSAY • Procedure Solution A: 200 mg/mL of sodium hydroxide in water Internal standard solution: 25 µg/mL of USP Amantadine Hydrochloride RS in water Standard stock solution: 25 µg/mL of USP Memantine Hydrochloride RS prepared as follows. Weigh a suitable quantity of the Standard into a volumetric flask. Add methanol to fill 40% of the final flask volume, and sonicate. Dilute with water to volume. Standard solution: Pipet 4.0 mL each of Internal standard solution and Standard stock solution into a test tube. Add 2 mL of Solution A, and mix on a vortex mixer for 1 min. Add 4 mL of toluene, and mix on a vortex mixer for 3 min. Allow the two layers to separate. Inject the toluene layer. Sample stock solution: Nominally 20 µg/mL of memantine hydrochloride prepared as follows. Transfer a suitable number of Tablets to a volumetric flask to obtain a 0.1 mg/mL memantine hydrochloride solution. Add methanol to fill 40% of the final flask volume, and sonicate for 30 min with intermittent shaking. Add water to fill 40% of the final flask volume, and sonicate for 30 min with intermittent shaking. Dilute with water to volume, and centrifuge a portion for 10 min. Pipet a suitable volume of the clear centrifugate into a volumetric flask, and dilute with water to volume. Sample solution: Pipet 5.0 mL of the Sample stock solution, 4.0 mL of Internal standard solution, and 2 mL of Solution A into a test tube, and mix on a vortex mixer for 1 min. Add 4 mL of toluene, and mix on a vortex mixer for 5 min. Allow the two layers to separate. Inject the toluene layer. Blank: To 5.0 mL of 80 µL/mL of methanol in water add 2 mL Solution A, and mix on a vortex mixer for 1 min. Add 4.0 mL of tolune, and cyclomix on vortex for 5 min. Allow the two layers to separate. Inject the toluene layer. Chromatographic system (See Chromatography 621 , System Suitability.) Mode: GC Detector: Flame ionization Column: 30-m × 0.32-mm; 0.25-µm packing G27 Temperatures Injection port: 210 Detector: 300 Oven: See Table 1. Table 1 Initial Temperature () Temperature Ramp (/min) Final Temperature () Hold Time at Final Temperature (min) 50 0 50 2 50 20 140 0 140 30 200 5 Carrier gas: Helium Flow rate: 34.8 psi Injection volume: 4 µL Injection type: Split ratio, 1:10 System suitability Sample: Standard solution [ NOTE— The relative retention times for amantadine and memantine are 0.97 and 1.0, respectively. ] Suitability requirements Resolution: NLT 2.0 between amantadine and memantine Tailing factor: NMT 2.5 for amantadine and NMT 2.0 for memantine Relative standard deviation: NMT 2.0% for the ratio of the peak areas of amantadine and memantine Analysis Samples: Standard solution, Sample solution, and Blank Calculate the percentage of the labeled amount of memantine hydrochloride (C12H21N ·HCl) in the portion of Tablets taken: Result = ( R U / R S ) × ( C S / C U ) × 100 R U = peak area ratio of memantine to amantadine from the Sample solution R S = peak area ratio of memantine to amantadine from the Standard solution C S = concentration of USP Memantine Hydrochloride RS in the Standard solution (µg/mL) C U = nominal concentration of memantine hydrochloride in the Sample solution (µg/mL) Acceptance criteria: 90.0%–110.0% PERFORMANCE TESTS • Dissolution 711 Medium: 0.1 N hydrochloric acid with sodium chloride (2g/L of sodium chloride in water), adjusted with hydrochloric acid to a pH of 1.2; 900 mL Apparatus 1: 100 rpm Time: 30 min Standard stock solution: (L/900) mg/mL of USP Memantine Hydrochloride RS in Medium, where L is the label claim in mg/Tablet Internal standard solution: 28 µg/mL of USP Amantadine Hydrochloride RS in Medium Standard solution For Tablets labeled to contain 5 mg: Transfer 5 mL of the Standard stock solution to a test tube, add 1 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer. For Tablets labeled to contain 10mg: Transfer 5 mL of the Standard stock solution to a test tube, add 2 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer. Sample solution: Pass a portion of the solution under test through a suitable filter. For Tablets labeled to contain 5 mg: Transfer 5 mL of the filtrate to a test tube, add 1 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer. For Tablets labeled to contain 10 mg: Transfer 5 mL of the filtrate to a test tube, add 2 mL of the Internal standard solution and 2 mL of 5 N sodium hydroxide, and mix for 1 min. Add 3 mL of toluene, and mix for 2 min. Use the toluene layer. Chromatographic system (See Chromatography 621 , System Suitability.) Mode: GC, splitless Detector: Flame ionization Column: 30-m × 0.32-mm; 0.25-µm packing G27 Flow rate: 34.8 psi Temperatures Injection port: 210 Detector: 300 Oven: See Table 2. Table 2 Initial Temperature () Temperature Ramp (/min) Final Temperature () Hold Time at Final Temperature (min) 50 0 50 2 50 20 140 0 140 30 200 5 Carrier gas: Helium Injection volume: 4 µL System suitability Sample: Standard solution Suitability requirements Resolution: NLT 2.0 between amantadine and memantine Tailing factor: NMT 2.0 each for amantadine and memantine Relative standard deviation: NMT 2.0% for both the amantadine and memantine peaks Analysis Samples: Standard solution and Sample solution Calculate the percentage of the labeled amount of memantine hydrochloride (C12H21N ·HCl) dissolved: Result = ( R u / R s ) × ( C s /L) × V × 100 R U = peak area ratio of memantine to amantadine from the Sample solution R S = peak area ratio of memantine to amantadine from the Standard solution C S = concentration of USP Memantine Hydrochloride RS from the Standard solution (µg/mL) V = volume of Medium, 900 mL L = label claim (mg/Tablet) Tolerances: NLT 80% (Q) of the labeled amount of memantine hydrochloride (C12H21N ·HCl) is dissolved. • Uniformity of Dosage Units 905 : Meet the requirements IMPURITIES • Limit of Memantine–Lactose Adduct [ NOTE— Perform this test if lactose is present in the formulation. ] Solution A: 40 mg/mL of sodium hydroxide in water Buffer: Dissolve 3.3 g of monobasic potassium phosphate and 2.3 g of sodium 1-octane sulfonate in 1 L of water. Adjust with Solution A to a pH of 6.1. Mobile phase: Acetonitrile, methanol, and Buffer (26:4:70) Standard solution: 0.2 mg/mL of USP Memantine Hydrochloride RS in Mobile phase Sample solution: Nominally 10 mg/mL of memantine hydrochloride from NLT 25 crushed Tablets, prepared as follows. Transfer an amount of powder equivalent to 100 mg of memantine hydrochloride to a 20-mL volumetric flask. Add 10 mL of Mobile phase, and sonicate for 30 min. Centrifuge, and pass a portion of the centrifugate through a suitable filter of 0.45-µm pore size. Chromatographic system (See Chromatography 621 , System Suitability.) Mode: LC Detector: Refractive index Column: 4.6-mm × 15-cm; 5-µm packing L1 Temperatures Column: 40 Detector: 35 Flow rate: 1.3 mL/min Injection volume: 50 µL Run time: 1.3 times the retention time of the memantine peak System suitability Sample: Standard solution Suitability requirements Tailing factor: NMT 3.5 Relative standard deviation: NMT 10.0% Analysis Samples: Standard solution and Sample solution Calculate the percentage of the memantine–lactose adduct in the portion of Tablets taken: Result = ( r U / r S ) × ( C S / C U ) × (1/F) × 100 r U = peak response of the memantine–lactose adduct from the Sample solution r S = peak response of memantine from the Standard solution C S = concentration of USP Memantine Hydrochloride RS in the Standard solution (mg/mL) C U = nominal concentration of memantine hydrochloride in the Sample solution (mg/mL) F = relative response factor of the memantine–lactose adduct (see Table 3) Acceptance criteria: See Table 3. Disregard all peaks other than the memantine–lactose adduct peak. Table 3 Name Relative Retention Time Relative Response Factor Acceptance Criteria, NMT (%) Memantine–lactose adduct 0.41 0.53 0.5 Memantine 1.0 1.0 — • Organic Impurities Solution A: 1 N sodium hydroxide Standard stock solution A: 0.5 mg/mL each of USP Memantine Related Compound A RS, USP Memantine Related Compound B RS, USP Memantine Related Compound C RS, USP Memantine Related Compound D RS, and USP Memantine Related Compound E RS in n-hexane Standard stock solution B: 12.5 mg/mL of USP Memantine Hydrochloride RS prepared as follows. Weigh a suitable quantity of the Standard into a volumetric flask. Add Solution A to fill 15% of the final flask volume and n-hexane to fill 10% of the final flask volume. Mix for 10 min. System suitability solution: Pipet 4.0 mL of the n-hexane layer from Standard stock solution B into a 10-mL volumetric flask. Add 0.5 mL of Standard stock solution A, and dilute with n-hexane to volume. Standard stock solution: 1.3 mg/mL of USP Memantine Hydrochloride RS in n-hexane prepared as follows. Weigh a suitable quantity of the Standard into a volumetric flask. Add Solution A to fill 30% of the final flask volume, and mix for 5 min. Add n-hexane to fill 40% of the final flask volume, and shake for 10 min. Transfer the contents of the flask into a separator. Allow the layers to separate, and filter a portion of the top n-hexane layer through anhydrous sodium sulfate. Use the clear solution. Standard solution: Pipet 2.0 mL of the clear solution from the Standard stock solution into a 100-mL volumetric flask, and dilute with n-hexane to volume. Sample solution: Nominally 5 mg/mL of memantine hydrochloride in n-hexane from NLT 20 crushed Tablets, prepared as follows. Transfer a weighed amount of powder equivalent to 100 mg of memantine hydrochloride to a suitable volumetric flask. Add Solution A to fill 15% of the final flask volume. Shake to disperse the material, and shake for 5 min. Sonicate for 5 min with intermittent shaking. Add n-hexane to fill 20% of the final flask volume, and shake for 10 min. Transfer the contents into a separator. Allow the layers to separate, and filter a portion of the top hexane layer through anhydrous sodium sulfate. Use the clear solution. Chromatographic system (See Chromatography 621 , System Suitability.) Mode: GC Detector: Flame ionization Column: 50-m × 0.32-mm; 0.52-µm packing G27 Temperatures Injection port: 220 Detector: 300 Oven: See Table 4. Table 4 Initial Temperature () Temperature Ramp (/min) Final Temperature () Hold Time at Final Temperature (min) 50 0 50 2 50 5 145 0 145 10 250 20 Carrier gas: Helium Flow rate: 4.0 ± 0.2 mL/min Injection volume: 3 µL Injection type: Split ratio, 1:20 System suitability Samples: System suitability solution and Standard solution [ NOTE— See Table 5 for the relative retention times. ] Suitability requirements Resolution: NLT 2.0 between memantine and memantine related compound B, NLT 2.0 between memantine related compound B and memantine related compound C, System suitability solution Tailing factor: NMT 2.0, Standard solution Relative standard deviation: NMT 10.0%, Standard solution Analysis Samples: Standard solution and Sample solution Calculate the percentage of USP Memantine Related Compound E RS or any individual degradation product in the portion of Tablets taken: Result = ( r U / r S ) × ( C S / C U ) × 100 r U = peak response of USP Memantine Related Compound E RS or any individual degradation product from the Sample solution r S = peak response of memantine hydrochloride from the Standard solution C S = concentration of USP Memantine Hydrochloride RS in the Standard solution (mg/mL) C U = nominal concentration of memantine hydrochloride in the Sample solution (mg/mL) Acceptance criteria: See Table 5. Table 5 Name Relative Retention Time Acceptance Criteria, NMT (%) Memantine related compound Aa 0.77 — Memantine 1.0 — Memantine related compound Ba 1.03 — Memantine related compound Ca 1.1 — Memantine related compound Da 1.2 — Memantine related compound E 1.4 0.15 Any individual unspecified degradation product — 0.20 Total impuritiesb — 0.5 a Process impurities controlled in the drug substance and are included for identification only. Not reported for the drug product and not included in the total impurities b Excludes memantine–lactose adduct monitored in the test for Limit of Memantine–Lactose Adduct. ADDITIONAL REQUIREMENTS • Packaging and Storage: Preserve in tight containers. Store at controlled room temperature. • USP Reference Standards 11 USP Amantadine Hydrochloride RS USP Memantine Hydrochloride RS USP Memantine Related Compound A RS 1,3-Dimethyladamantane. C12H20 164.29 USP Memantine Related Compound B RS 3,5-Dimethyladamantane-1-ol. C12H20O 180.29 USP Memantine Related Compound C RS 1-Chloro-3,5-dimethyladamantane. C12H19Cl 198.73 USP Memantine Related Compound D RS 1-Bromo-3,5-dimethyladamantane. C12H19Br 243.18 USP Memantine Related Compound E RS N-3,5-Dimethyladamantan-1-yl formamide. C13H21NO 207.31 |
» 本帖已获得的红花（最新10朵）
zhangpeino5楼2013-10-20 23:02:07